Find Mirvie
in the news

Find Mirvie in
the news

Find Mirvie in
the news

APRIL 27, 2021

Mirvie is redefining pregnancy health by developing the first early detection RNA test to address pregnancy complications which impact 45 million women globally

  • Pregnancy complications affect 45 million women globally each year, five times the rate of cancer incidence. Today there is no reliable way to identify those pregnancies at-risk.
  • The goal of Mirvie’s simple blood test is the early detection of complications such as preterm birth, preeclampsia and gestational diabetes, which has the potential to reduce pregnancy healthcare costs by up to 65%.
  • Mirvie is led by a team of pioneers in women’s health, perinatal health, early cancer detection, liquid biopsy and gene sequencing.

SAN FRANCISCO – April 27, 2021 – Mirvie, a pioneer in pregnancy health, today announced it is making rapid progress toward developing a simple, personalized blood test with the potential for early detection of pregnancy complications, such as preterm birth, preeclampsia and gestational diabetes, which affect 1 in 5 women. Currently, there is no reliable way to identify if a mother is at risk for these significant pregnancy complications.

Mirvie’s novel technology has the potential to reduce pregnancy healthcare costs by up to 65%
Personalized results using state-of-the-art machine learning and RNA liquid biopsy technology
Pregnancy complications account for over $50 billion in healthcare costs in the U.S. and E.U. alone

Pregnancy complications affect 45 million women globally each year, five times the rate of cancer incidence

Mirvie has raised over $30M in early-stage financing to address the large unmet need in pregnancy health

PRESS

Cell-Free RNA Testing For Pregnancy Complications

Mirvie is developing a revolutionary, cell-free RNA test using a simple blood sample to assess the risk of developing severe pregnancy complications.

Improving Pregnancy Health: How We Can Predict Challenges Sooner

Obstetrics has improved in treating conditions like preterm birth and preeclampsia, but the ability to predict who’s at risk is “ripe for exploration and innovation.”

Meet Mirvie, a Femtech Startup Creating a Blood Test for Early Detection of Pregnancy Complications

Earlier today Mirvie announced it is making rapid progress toward developing a simple, personalized blood test with the potential for early detection of pregnancy complications, such as preterm birth, preeclampsia and gestational diabetes, which affect 1 in 5 women. Currently, there is no reliable way to identify if a mother is at risk for these significant pregnancy complications.…

Noninvasive blood tests for fetal development predict gestational age and preterm delivery.

Low-cost methods for monitoring fetal development could improve prenatal care, especially in low-resource settings. By measuring the levels of certain placental RNA transcripts in maternal blood…

10 Breakthrough Technologies 2019 – How we’ll invent the future.

by Bill Gates

We asked Gates to choose this year’s list of inventions that will change the world for the better. I was honored when MIT Technology Review invited me to be the first guest curator of its 10 Breakthrough Technologies…

Complications from preterm birth are the leading cause of death worldwide in children under five.

by Bonnie Rochman

Fifteen million babies are born pre­maturely each year. Stephen Quake’s daughter, Zoe, was one of them: she arrived via emergency C-section after Quake and his wife, Athina, made a middle-of-the-night dash to the emergency room, a month before Zoe was due. She spent her first night in an incubator, and her father, a bioengineer then at Caltech, wondered why birth couldn’t be more predictable…

Cell-Free RNA Testing For Pregnancy Complications

Mirvie is developing a revolutionary, cell-free RNA test using a simple blood sample to assess the risk of developing severe pregnancy complications.

Improving Pregnancy Health: How We Can Predict Challenges Sooner

Obstetrics has improved in treating conditions like preterm birth and preeclampsia, but the ability to predict who’s at risk is “ripe for exploration and innovation.”

Meet Mirvie, a Femtech Startup Creating a Blood Test for Early Detection of Pregnancy Complications

Earlier today Mirvie announced it is making rapid progress toward developing a simple, personalized blood test with the potential for early detection of pregnancy complications, such as preterm birth, preeclampsia and gestational diabetes, which affect 1 in 5 women. Currently, there is no reliable way to identify if a mother is at risk for these significant pregnancy complications.…

Noninvasive blood tests for fetal development predict gestational age and preterm delivery.

Low-cost methods for monitoring fetal development could improve prenatal care, especially in low-resource settings. By measuring the levels of certain placental RNA transcripts in maternal blood…

10 Breakthrough Technologies 2019 – How we’ll invent the future.

by Bill Gates

We asked Gates to choose this year’s list of inventions that will change the world for the better. I was honored when MIT Technology Review invited me to be the first guest curator of its 10 Breakthrough Technologies…

Complications from preterm birth are the leading cause of death worldwide in children under five.

by Bonnie Rochman

Fifteen million babies are born pre­maturely each year. Stephen Quake’s daughter, Zoe, was one of them: she arrived via emergency C-section after Quake and his wife, Athina, made a middle-of-the-night dash to the emergency room, a month before Zoe was due. She spent her first night in an incubator, and her father, a bioengineer then at Caltech, wondered why birth couldn’t be more predictable…